A dosing algorithm for metformin based on the relationships between exposure and renal clearance of metformin in patients with varying degrees of kidney function

Cancer risk in patients aged 30 years and above with type 2 diabetes receiving antidiabetic monotherapy: a cohort study using metformin as the comparator

(2015) Victor Kok et al.   Therapeutics and Clinical Risk Management

Population Pharmacokinetics of Metformin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus: Simulation of Doses According to Renal Function

(2013) Janna K. Duong et al.   CLINICAL PHARMACOKINETICS

The Role of Metformin in Metformin-Associated Lactic Acidosis (MALA): Case Series and Formulation of a Model of Pathogenesis

(2013) Janna K. Duong et al.   DRUG SAFETY

Metformin therapy in patients with chronic kidney disease

(2012) J. K. Duong et al.   DIABETES OBESITY & METABOLISM

Establishment of a Database of Metformin Plasma Concentrations and Erythrocyte Levels in Normal and Emergency Situations

(2011) Jean-Daniel Lalau et al.   CLINICAL DRUG INVESTIGATION

Clinical Pharmacokinetics of Metformin

(2011) Garry G. Graham et al.   CLINICAL PHARMACOKINETICS

Piraña and PCluster: A modeling environment and cluster infrastructure for NONMEM

(2010) Ron J. Keizer et al.   COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE

Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions

(2009) Radojka M. Savic et al.   AAPS Journal

Lean body mass normalizes the effect of obesity on renal function

(2008) Sarayut Janmahasatian et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE